We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$82.8B
AUM Growth
+$476M
Cap. Flow
+$2.41B
Cap. Flow %
2.92%
Top 10 Hldgs %
28.47%
Holding
1,479
New
286
Increased
466
Reduced
429
Closed
252

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.52B
2
SU icon
Suncor Energy
SU
+$838M
3
MSFT icon
Microsoft
MSFT
+$689M
4
XOM icon
ExxonMobil
XOM
+$480M
5
CVX icon
Chevron
CVX
+$470M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$425M
2
ORCL icon
Oracle
ORCL
+$415M
3
UNP icon
Union Pacific
UNP
+$360M
4
PYPL icon
PayPal
PYPL
+$322M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 27.28%
2 Consumer Discretionary 16.12%
3 Communication Services 13.52%
4 Healthcare 13.04%
5 Financials 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1451
Zoetis
ZTS
$30.9B
-152,498
Closed -$26.3M
TXNM
1452
TXNM Energy Inc
TXNM
$5.91B
-35,821
Closed -$1.62M
NBIS
1453
Nebius Group N.V.
NBIS
$46.7B
$0 ﹤0.01%
32,887
LUCK
1454
Lucky Strike Entertainment
LUCK
$893M
-1,671,368
Closed -$19.5M
TVRD
1455
Tvardi Therapeutics
TVRD
$22M
-5,553
Closed -$566K
LGF.A
1456
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-57,673
Closed -$509K
ENFN
1457
DELISTED
Enfusion, Inc.
ENFN
-27,763
Closed -$312K
ITCI
1458
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-9,671
Closed -$612K
VOXX
1459
DELISTED
VOXX International Corporation Class A
VOXX
-105,461
Closed -$1.32M
PSTX
1460
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-99,598
Closed -$175K
INST
1461
DELISTED
Instructure Holdings, Inc.
INST
-14,482
Closed -$364K
SRCL
1462
DELISTED
Stericycle Inc
SRCL
-109,857
Closed -$5.1M
ITI
1463
DELISTED
Iteris, Inc.
ITI
-73,017
Closed -$289K
CONN
1464
DELISTED
Conn's Inc.
CONN
-42,361
Closed -$157K
SLCA
1465
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-16,349
Closed -$198K
SIX
1466
DELISTED
Six Flags Entertainment Corp.
SIX
-540,518
Closed -$14M
SWAV
1467
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-12,647
Closed -$3.61M
CAMP
1468
DELISTED
CalAmp Corp.
CAMP
-2,179
Closed -$53K
NEWR
1469
DELISTED
New Relic, Inc.
NEWR
-20,165
Closed -$1.32M
NATI
1470
DELISTED
National Instruments Corp
NATI
-9,331
Closed -$536K
TRTN
1471
DELISTED
Triton International Limited
TRTN
-613,665
Closed -$51.1M
BKI
1472
DELISTED
Black Knight, Inc. Common Stock
BKI
-468,151
Closed -$28M
NUVA
1473
DELISTED
NuVasive, Inc.
NUVA
-762,612
Closed -$31.7M
PDCE
1474
DELISTED
PDC Energy, Inc.
PDCE
-365,704
Closed -$26M
UNVR
1475
DELISTED
Univar Solutions Inc.
UNVR
-29,840
Closed -$1.07M

Similar funds

Arrowstreet Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Arrowstreet Capital held 1,479 positions worth $82.8B, up 0.58% from $82.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Arrowstreet Capital's Q3 2023 filing shows 286 new, 466 increased, 429 reduced and 252 closed positions. Its largest new stake was Canadian Natural Resources: 9,967,632 shares worth $323M. The largest sale was Discover Financial Services, an estimated $425M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Arrowstreet Capital's largest Q3 2023 buy was Canadian Natural Resources: 9,967,632 shares worth $323M.
  • Arrowstreet Capital added most to Apple in Q3 2023, an estimated $1.52B increase.
  • Arrowstreet Capital's biggest Q3 2023 reduction was Oracle, cutting an estimated $415M.
  • Arrowstreet Capital fully exited Discover Financial Services in Q3 2023, selling an estimated $425M.
  • Arrowstreet Capital's ten largest holdings make up 28% of its $82.8B portfolio in Q3 2023.
  • Arrowstreet Capital opened 286 new positions and closed 252 in Q3 2023.
  • Arrowstreet Capital's portfolio value rose 0.58% quarter-over-quarter to $82.8B.

Based on Arrowstreet Capital's 13F filing for Q3 2023, filed 14 Nov 2023.